Abstract. To elucidate the mechanism of hypogonadotropic hypogonadism in a patient with X-linked congenital adrenal hypoplasia, we studied the effects on serum LH and FSH of repeated iv administration of GnRH 
days), pulsatile sc administration of GnRH (5 \ g=m\ gevery 90 min during days 1~56, 10 \ g=m\ gevery 90 min during days 57~9 1) and an iv bolus injection of 10 mg of naloxone. The repeated administration of GnRH restored the hyporesponsiveness of serum FSH and increased serum testosterone level from < 1.0 to 1.7 nmol/l, but the impaired LH response to the standard GnRH test was not improved. The pulsatile administration of GnRH for 91 consecutive days did not induce a clinical or a biochemical change of puberty. Serum testosterone remained undetectable < 1.0 nmol/l, the hyporesponsiveness of serum LH was not improved, but basal FSH level was significantly increased and the impaired FSH response to the standard GnRH test was slightly improved. Naloxone had no effect on serum LH or FSH before or during the pulsatile administration. We conclude that hypogonadotropic hypogonadism in our patient is due to the pituitary dysfunction and that the endogenous opioid peptides may not play a role in the mechanism of inhibited gonadotropin secretions.
X-linked congenital adrenal hypoplasia (X-linked CAH) is known to be associated with hypogonado¬ tropic hypogonadism (Prader et (GnRH) . However, the mechanism of hypogo¬ nadotropic hypogonadism remains unclear.
Hypothalamic hypogonadism can be distin¬ guished from pituitary hypogonadism by the re¬ sponse to repeated administration of GnRH (Yoshimoto et al. 1975; Snyder et al. 1979 2) The responses to the pulsatile administration of 0, 7, 14, 21, 28, 35, 42, 49, 56,63, 70, 77 and 84. 3) 2) The responses to the pulsatile administration ofGnRH Fig. 2 3) The effects of naloxone on serum LH and FSH 3a) Fig. 3 (Fig. 4A) . Serum LH and FSH levels (mean ± SD) in blood samples taken every 15 min were 11.3 ± 1.9 IU/1 (N = 18) and 3.6 ± 0.7 IU/1 (N = 18), respectively. Fig. 4B shows that the UH and FSH surges were not induced by the pulsatile administration of GnRH on day 91, and that naloxone did not improve the UH and FSH re¬ sponses to the pulsatile administration. However, a significant (P < 0.001) increase in the serum FSH level (5.7 ± 0.5 IU/1, = 18) was observed as compared with that at the age of 16 10/12 years, whereas no significant alteration in the serum LH level (10.8 ± 1.4 IU/1, = 18) was observed. The responses of a male control patient with panhypopituitarism owing to suprasellar germinoma are shown for comparison in Fig. 4C .
Discussion
The restoration of the impaired FSH response and the increase in serum testosterone by re¬ peated iv administration of 400 µg of GnRH for 
